Amgen (AMGN) Shareholder's Equity Growth (1y) (2010 - 2026)

Amgen (AMGN) Shareholder's Equity Growth (1y) (2010 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 48.06%
Dec 31, 2025 47.32%
Sep 30, 2025 27.79%
Jun 30, 2025 25.37%
Mar 31, 2025 23.60%
Dec 31, 2024 -5.70%
Sep 30, 2024 -1.68%
Jun 30, 2024 -12.62%
Mar 31, 2024 -6.10%
Dec 31, 2023 70.23%
Sep 30, 2023 109.58%
Jun 30, 2023 180.32%
Mar 31, 2023 483.84%
Dec 31, 2022 -45.36%
Sep 30, 2022 -55.54%
Jun 30, 2022 -70.67%
Mar 31, 2022 -90.19%
Dec 31, 2021 -28.79%
Sep 30, 2021 -25.02%
Jun 30, 2021 -22.63%